Prophenoloxidase-activating Proteinase-2 from Hemolymph of Manduca sexta

A BACTERIA-INDUCIBLE SERINE PROTEINASE CONTAINING TWO CLIP DOMAINS*

Haobo JiangDagger §, Yang WangDagger , Xiao-Qiang Yu, and Michael R. Kanost

From the Dagger  Department of Entomology and Plant Pathology, Oklahoma State University, Stillwater, Oklahoma 74078 and the  Department of Biochemistry, Kansas State University, Manhattan, Oklahoma 66506

Received for publication, June 10, 2002, and in revised form, October 18, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Proteolytic activation of prophenoloxidase in insects is a component of the host defense system against invading pathogens and parasites. We have purified from hemolymph of the tobacco hornworm, Manduca sexta, a new serine proteinase that cleaves prophenoloxidase. This enzyme, designated prophenoloxidase-activating proteinase-2 (PAP-2), differs from another PAP, previously isolated from integuments of the same insect (PAP-1). PAP-2 contains two clip domains at its amino terminus and a catalytic domain at its carboxyl terminus, whereas PAP-1 has only one clip domain. Purified PAP-2 cleaved prophenoloxidase at Arg51 but yielded a product that has little phenoloxidase activity. However, in the presence of two serine proteinase homologs, active phenoloxidase was generated at a much higher level, and it formed covalently linked, high molecular weight oligomers. The serine proteinase homologs associate with a bacteria-binding lectin in M. sexta hemolymph, indicating that they may be important for ensuring that the activation of prophenoloxidase occurs only in the vicinity of invading microorganisms. PAP-2 mRNA was not detected in naive larval fat body or hemocytes, but it became abundant in these tissues after the insects were injected with bacteria.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Phenoloxidase (PO)1 is implicated in several defense mechanisms in insects, including cuticle sclerotization and melanotic encapsulation (1-3). Quinones produced by phenoloxidase may also participate in wound healing and killing of sequestered parasites and pathogens (4). To minimize detrimental effects of the reactive intermediates to host tissues and cells, arthropod phenoloxidases known so far are all produced as inactive proenzymes and require specific proteinases for proteolytic activation.

Activation of proPO in insects is probably mediated by a serine proteinase cascade, analogous to the coagulation pathway and complement system in human plasma (1, 2, 5, 6). Components of this proteinase system in insects may be already present in circulating hemolymph or released from hemocytes or fat body when pathogens or parasites are encountered. Recognition of invading microorganisms or aberrant host tissues may trigger the autoactivation of the first proteinase in the pathway, leading to the sequential activation of other components in the system through limited proteolysis. Prophenoloxidase-activating proteinase (PAP) (also known as prophenoloxidase-activating enzyme (PPAE)) is the terminal enzyme that directly converts proPO to PO. The reactions catalyzed by phenoloxidase can then result in melanization of foreign organisms trapped in capsules or hemocyte nodules (7). Presumably, protein-protein interactions ensure that the defense response occurs near the site of infection. Inhibitors of serine proteinases and phenoloxidases may further reduce unwanted damage caused by the active enzymes (8).

The molecular mechanisms of proPO activation have been investigated in several insect species. We have isolated a PAP from a cuticular extract of the tobacco hornworm, Manduca sexta (9). This serine proteinase, now renamed PAP-1, hydrolyzes a synthetic peptidyl-p-nitroanilide substrate but requires another protein factor for generating active PO. A cDNA clone for PAP-1 was obtained from an M. sexta hemocyte library. Sequence comparison indicated that the protein belongs to a family of arthropod serine proteinases containing a clip domain (10, 11).

In this paper, we report the purification and characterization of a second serine proteinase from M. sexta hemolymph that activates proPO. To distinguish it from PAP-1 isolated previously from cuticles (9), we designate this new proteinase PAP-2. Molecular cloning of PAP-2 indicates that it is most similar to the silkworm PPAE and has two clip domains at its amino terminus (12). The PAP-2 zymogen is present at a higher level in hemolymph of M. sexta larvae that were challenged with killed bacteria. PAP-2 requires serine proteinase homologs from M. sexta plasma (13) as cofactors for proPO activation. Since the serine proteinase homologs associate with immulectin-2, a C-type lectin isolated from Manduca hemolymph (13-15), they may serve as anchoring/auxiliary factors for PAP-2 so that proPO activation only occurs as a local defense response against nonself.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Insects and Hemolymph Collection-- M. sexta eggs were originally purchased from Carolina Biological Supply, and larvae were reared on an artificial diet (16). Pharate pupae with metathoracic brown bars were chilled and dissected for hemolymph collection. When all tissues were cautiously removed from the integument with a spatula, hemolymph was pooled and collected carefully with a 1-ml pipetter, avoiding contaminating tissue fragments. This method yields significantly greater amounts of hemolymph than cutting a proleg of pharate pupae, because their hemolymph volume is quite low. Individual hemolymph samples (0.8-1 ml/insect) were immediately mixed with 100% saturated ammonium sulfate (pH 7.0) to prevent the rapid melanization of hemolymph, which occurs at this developmental stage. The ammonium sulfate was adjusted to 50% saturation, and the suspension was stored at -70 °C. Hemolymph collected this way contains many active proteinases and is stable for at least 2 years. For the bacterial induction experiment, fifth instar M. sexta larvae (day 2) were injected with Micrococcus luteus (10 µl/larva, 10 µg/µl; Sigma), formalin-killed Escherichia coli XL1-blue (108 cells/larva, 10 µl), or H2O (10 µl) as a negative control.

Measurement of proPO Activation and Amidase Activity-- proPO was purified from M. sexta larval hemolymph as described previously (17). Column fractions (10 µl) were mixed with 0.5 µg of proPO and 20 mM Tris-HCl, 5 mM CaCl2, pH 7.5, to a final volume of 20 µl. The reaction mixtures were incubated in microplate wells on ice for 60 min. PO activity was measured by adding 200 µl of 2 mM dopamine in 50 mM sodium phosphate, pH 6.5, to each sample well. Absorbance at 470 nm was then monitored continuously using a microplate reader (Molecular Devices). One unit of PAP activity is defined as the amount of enzyme yielding PO that produces an increase of 0.001 absorbance units/min.

Amidase activity was assayed by using acetyl-Ile-Glu-Ala-Arg-p-nitroanilide (A0180; Sigma) as a chromogenic substrate. Samples of column fractions (10-20 µl) were mixed with 200 µl of 50 µM substrate in 0.1 M Tris-HCl, 0.1 M NaCl, 5 mM CaCl2, pH 7.8. One unit of activity is defined as Delta A405/min = 0.001.

Initial Isolation of PAP-2-- Since a detailed, optimized purification scheme is presented below, we briefly describe here how PAP-2 was first isolated from M. sexta hemolymph. Unless otherwise specified, conditions for separation remained the same in the first and second PAP-2 purification. The plasma (42.5 ml) from bar stage prepupae was first fractionated with 15-40% saturation of ammonium sulfate and then dialyzed before separation on a hydroxylapatite column. Fractions were assayed for PO and proPO-activating activities. The fractions that activated proPO were pooled, concentrated in a Centriplus-30 (Millipore Corp.), and applied to a Sephacryl S100-HR column. Since proPO-activating activity was low in this and the following steps, acetyl-Ile-Glu-Ala-Arg-p-nitroanilide hydrolysis (Sigma) was used to monitor an amidase activity (IEARase) that activates proPO only in the presence of other protein factors. Combined fractions of IEARase were passed through concanavalin A (ConA)-Sepharose 4B (5 ml; Amersham Biosciences) and Jacalin-agarose columns (5 ml; Vector Laboratories) to remove minor proteins that are difficult to separate in the final step. The unbound fraction from the lectin affinity columns was concentrated in a Centriplus-30 concentrator, and buffer exchange was carried out in the same centrifugal filter device. The sample was separated by HPLC on an MA7Q anion exchange column (Bio-Rad). Fractions containing the IEARase activity were individually concentrated in a Microcon-30 concentrator (Millipore Corp.).

Amino Acid Sequence Determination-- The partially purified IEARase (PAP-2) was treated with SDS-sample buffer containing 2-mercaptoethanol and separated by electrophoresis on a 12% polyacrylamide gel (18). The protein was then transferred to a polyvinylidene difluoride membrane and stained with Amido Black (Sigma). The 35-kDa polypeptide, which corresponded to a [3H]DFP-labeled band detected as described by Jiang et al. (9), was subjected to automated Edman degradation. To determine the amino-terminal sequence of its 25-kDa light chain, purified PAP-2 (2 µg) was mixed with 1 µg of pyroglutamate aminopeptidase (Roche Molecular Biochemicals) in 100 µl of 100 mM sodium phosphate (pH 8.0) containing 10 mM EDTA, 5 mM dithiothreitol, 5% glycerol (v/v), and 1 mM p-aminobenzamidine. The reaction was carried out at 4 °C for 18 h followed by 25 °C for 4 h. The proteins in the mixture were precipitated by trichloroacetic acid at a final concentration of 10%. After centrifugation, the pellet was washed with cold anhydrous acetone and dissolved in 20 µl of the SDS sample buffer at 95 °C for 5 min. After gel separation and transfer, the first six residues of the 25-kDa band were determined as described above.

Molecular Cloning and Sequence Analysis of PAP-2-- lambda phage DNA (0.1 µg) isolated from a bacteria-induced fat body cDNA library was used as a template in a PCR to amplify a PAP-2 cDNA fragment. Two degenerate primers were designed based on the amino-terminal sequence of PAP-2 catalytic domain: 660 (5'-ACA GCC ATC GAY CAR TAY CCN TGG-3') and 661 (5'-G CTG GCG CTG ATH GAR TAY CAY AA-3'), which encode TAIDQYPW and LALIEYHK, respectively. Primer 625 (5'-CAT GAG SGG RCC RCC SGA RTC NCC-3') is the reverse complement of the sequence encoding GDSGGPLM, a highly conserved sequence around the active site serine residue in the chymotrypsin family of serine proteinases. In a first PCR, primer 660 was used with primer T7, which anneals with sequence in the cloning vector near the 3'-end of the inserted cDNA, under the following conditions: 94 °C, 30 s; 53 °C, 40 s; and 72 °C, 80 s for 30 cycles. The reaction product (1 µl) was used directly as a template for a second, nested PCR by using primers 661 and 625 under the same cycling conditions. After electrophoresis of the resulting products on a 1% agarose gel, a DNA band of the expected size (about 0.6 kb) was recovered and cloned into the pGem-T vector (Promega). After this clone was confirmed by DNA sequence analysis to encode PAP-2, the PCR-derived cDNA fragment was labeled by 32P and used as a probe to screen the induced M. sexta fat body cDNA library in lambda ZAP II (Stratagene) (19). Positive clones were purified to homogeneity and subcloned by in vivo excision of pBluescript phagemids. Nucleotide sequence analysis was carried out using the BigDye Terminator Cycle Sequencing Ready Reaction Kit (PE Applied Biosystems).

Northern and Western Blot Analyses of PAP-2 mRNA and Protein Levels-- Fat body and hemocyte total RNA samples were prepared according to Wang et al. (20), separated by electrophoresis in agarose gels containing formamide, transferred to nitrocellulose, and hybridized with 32P-labeled PAP-2 cDNA. A duplicate blot was hybridized with a cDNA for M. sexta ribosomal protein S3 (21) as a loading control. To detect a possible change of proPAP-2 in larval hemolymph upon bacterial challenge, Manduca larvae were injected with buffer, Escherichia coli, or M. luteus. Cell-free hemolymph samples collected at 24 h after injection were resolved by electrophoresis on an SDS-polyacrylamide gel (18). Immunoblot analysis was performed using the polyclonal antiserum to proPAP-2 as the first antibody.2

Optimized Purification of PAP-2-- All procedures for purification of PAP-2 were carried out at 4 °C. A frozen bar stage hemolymph sample (40 ml) was thawed, and the protein precipitate was collected by centrifugation at 12,000 × g for 25 min. The pellet was resuspended in 80 ml of HT buffer (pH 6.8, 10 mM potassium phosphate, 0.5 M NaCl), supplemented with 0.001% 1-phenyl-2-thiourea and 0.5 mM p-aminobenzamidine. To remove the beta -1,3-glucan recognition proteins in the hemolymph (22), curdlan (0.2 g) was incubated with the protein solution with gentle agitation for 10 min on ice. The reaction mixture was centrifuged at 15,000 × g for 30 min to remove the flocculent materials including curdlan. Saturated ammonium sulfate solution was slowly added to the supernatant to a final saturation of 35%. After centrifugation at 15,000 × g for 30 min, the pellet was collected and dissolved in 20 ml of HT buffer. The fractionated plasma sample was dialyzed against the same buffer (1.0 liter for 8 h, twice), and the resulting particulate substances were removed by passing the sample through a syringe filter (0.45 µm, low protein binding; Fisher).

The protein solution was diluted with equal volume of H2O and applied to a hydroxylapatite column (2.5-cm inner diameter × 7 cm; Bio-Rad) equilibrated with 0.5 × HT buffer. Following a washing step with 60 ml of 0.5× HT and 50 ml of 1× HT buffers, bound proteins were eluted at 0.5 ml/min for 4 h with a linear gradient of 20-150 mM potassium phosphate (pH 6.8), 0.5 M NaCl. Fractions were analyzed by immunoblotting and an IEARpNa amidase assay. Active fractions containing PAP-2 were combined and precipitated with ammonium sulfate (60% saturation). The precipitate was collected by centrifugation at 15,000 × g for 30 min, dissolved in 3.0 ml, 20 mM Tris-HCl, 0.5 M NaCl, pH 7.5 (S100 buffer), and then immediately applied to a Sephacryl S100-HR column (2.5-cm inner diameter × 100 cm; Amersham Biosciences) equilibrated with the same buffer. The column was eluted with S100 buffer at a flow rate of 0.7 ml/min, and fractions were collected at 2.5 ml/tube after the first 100 ml.

Fractions containing PAP-2 were pooled and supplemented with CaCl2 and MgCl2 at a final concentration of 1 mM each. The sample was loaded onto a ConA-Sepharose 4B column (5.0 ml) equilibrated with 20 mM Tris-HCl, 0.5 M NaCl, 1 mM CaCl2, 1 mM MgCl2, pH 7.4 and washed with the same buffer until A280 was lower than 0.05.

The flow-through fraction was dialyzed against Q buffer (25 mM Tris-HCl, pH 7.5), supplemented with 0.5 mM p-aminobenzamidine (2 liters each time for 8 h, twice). After passing through a syringe filter, the dialyzed sample (45 ml) was applied to a UNO-Q6 column (6 ml; Bio-Rad) equilibrated by Q buffer. Following a washing step, the bound proteins were eluted with a gradient of 0-0.2 M NaCl in Q buffer at a flow rate of 1.0 ml/min for 30 min. This step was performed in a cold chamber using a Biologic Duo-Flow Protein Purification System (Bio-Rad). Fractions (0.5 ml/tube) were collected and analyzed by electrophoresis on a SDS-polyacrylamide gel (10%) followed by silver staining (23) or immunoblot analysis. Affinity labeling with [3H]DFP and fluorographic detection of PAP-2 were carried out according to Skinner and Griswold (24). Purified PAP-2 was stored at -70 °C for characterization and activity assays.

MALDI Mass Spectrometry of PAP-2 and Cleaved proPO-- The purified PAP-2 was desalted using a C18 zip tip (Millipore) and eluted with 70% acetonitrile, 0.1% trichloroacetic acid. The sample was mixed with an equal volume of saturated sinapinic acid matrix on a MALDI plate, air-dried, and subjected to mass determination on a Voyager Elite mass spectrometer (PerkinElmer Life Sciences) with delayed extraction. The spectra were calibrated using bovine serum albumin as an external standard.

To determine the site at which PAP-2 cleaves proPO, 1.0 µg of proPO was incubated with 0.2 µg of PAP-2 on ice for 60 min, and the reaction mixture was desalted and eluted as described above. Molecular masses of peaks that were not present in the control spectra of proPO and PAP-2 were compared with calculated values of the amino-terminal peptides to determine the cleavage site in proPO.

Activation of proPO by PAP-2 in the Presence of Serine Proteinase Homologs (SPHs)-- The SPH-1 and -2 were isolated from induced larval hemolymph according to Yu et al. (13). The protein preparation (10 µl) was incubated with 40 µl of 5 mM phenylmethylsulfonyl fluoride (Sigma) in 5 mM CaCl2, 25 mM Tris-HCl (pH 7.5) at 4 °C for 16 h to inactivate serine proteinases that might be associated with the SPHs. The treated sample was dialyzed against the same buffer without phenylmethylsulfonyl fluoride (100 ml/8 h each time, twice). To test the effect of M. sexta SPH-1 and SPH-2 on the activation of proPO, purified proPO was incubated with buffer, PAP-2, SPH-1 and -2, or a mixture of PAP-2 and the SPHs at 4 °C for 60 min. PO activity in the reaction mixtures was assayed, using dopamine as a substrate. As described in the legend to Fig. 6, the reaction mixtures were also subjected to electrophoresis followed by silver staining or immunoblot analysis using antiserum against Manduca proPO (diluted 1:2000) as the first antibody. To study whether PO activity is involved in the formation of SDS-stable PO polymers, we included 0.001% 1-phenyl-2-thiourea (PTU), a PO inhibitor, in some of the reaction mixtures and analyzed the samples similarly.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Partial Purification of PAP-2 and Its Requirement for a Cofactor-- Preliminary experiments indicated that active PO and proteinases are already present in the hemolymph of bar stage prepupal M. sexta larvae in the absence of microbial challenge. As a step toward understanding the prophenoloxidase-activating system in M. sexta hemolymph, we attempted to purify a PAP from plasma of bar stage insects. To preserve the enzyme activities and minimize protein cross-linking caused by active PO, we kept the plasma and column fractions at high salt concentrations in the presence of inhibitors of phenoloxidase and proteases. Based on our previous experience with the cuticular PAP (PAP-1) (9), we employed three different assays to follow each purification step: proPO activation, [3H]DFP labeling, and an amidase assay using acetyl-Ile-Glu-Ala-Arg-p-nitroanilide as a substrate. Among the commercially available peptidyl-p-nitroanilide substrates, IEARpNa is most similar to the amino-terminal side of the putative activation site in M. sexta proPO-p1 (Leu-Ser-Asn-Arg51) and proPO-p2 (Leu-Asn-Asn-Arg51) (17). When the 15-40% ammonium sulfate fraction of the cell-free hemolymph was separated on a hydroxylapatite column, the proPO-activating activity roughly coincided with one of the IEARase peaks (data not shown). These fractions were pooled, concentrated, and then resolved by gel filtration chromatography on a Sephacryl S100-HR column (Fig. 1A). We detected a major IEARase activity peak in fractions 30-34 as well as low levels of IEARpNa hydrolysis in some other column fractions. This amidase peak did not correspond to the proPO-activating activity found in fractions 10-16 (data not shown). The proPO-activating activity in all of the fractions accounted for only 5-10% of the total activity loaded onto the column. One possibility is that, like PAP-1 (9), proPO activation is mediated by a complex of a proteinase and a protein cofactor, and separation of this complex led to the low activity of PAP-2.


View larger version (37K):
[in this window]
[in a new window]
 
Fig. 1.   Partial purification of M. sexta PAP-2 and requirement of a cofactor for proPO activation. A, gel filtration chromatography of partially purified PAP-2 from hemolymph of bar stage insects. As described under "Experimental Procedures," a 15-40% ammonium sulfate (AS) fraction of the plasma sample was separated by hydroxylapatite chromatography. Concentrated fractions that activated proPO and hydrolyzed IEARpNa were combined and resolved on a Sephacryl S100-HR column (2.5-cm inner diameter × 120 cm) with 20 mM Tris-HCl, 0.5 M NaCl, pH 7.5. open circle ------open circle , absorbance at 280 nm; black-diamond ------black-diamond , amidase activity (units) in 10 µl of the fraction measured with IEARpNa. B, activation of proPO by S-100 column fractions. M. sexta proPO (0.2 µg) was incubated with a sample from the high molecular weight peak (fraction 14, 2 µl), a sample from the IEARase activity peak (fraction 32, 2 µl), or a mixture of these two samples (14 + 32, 2 µl + 2 µl) in pH 7.5, 20 mM Tris-HCl, 5 mM CaCl2 on ice for 60 min. Phenoloxidase activity in the reaction mixtures and the controls of fraction 14 (2 µl), fraction 32 (2 µl), proPO (0.2 µg), and a mixture of fractions 14 and 32 (2 µl + 2 µl) were measured as described under "Experimental Procedures." C, analysis of MA7Q column fractions by SDS-polyacrylamide gel electrophoresis. After removal of some glycoproteins by the lectin affinity columns, the IEARase activity peak was further separated by HPLC on an anion exchange column. Concentrated active fractions 26-28 (equivalent to 120 µl of the unconcentrated sample) were subjected to SDS-polyacrylamide gel electrophoresis followed by Coomassie Blue staining. C and R, catalytic and regulatory domains of PAP-2. M, protein molecular mass standards.

To test this hypothesis, we incubated aliquots of fraction 32 with a small amount of other column fractions for 1 h along with purified proPO. Fraction 32 did not contain PO activity, and it generated little active PO when incubated with proPO (Fig. 1B). After fraction 32 was incubated with proPO in the presence of fraction 10-16, which contained only low levels of PO and proPO-activating activities, a large increase in PO activity was observed. This result supported the hypothesis that proPO activation requires PAP and a cofactor. Because high amidase activity was detected in fraction 32 but not in fraction 14, we concluded that the PAP is probably present in fraction 32 and that the cofactor is in fraction 14. Their molecular masses are estimated to be about 50 and 200-500 kDa, respectively, based on their elution volume from the Sephacryl S-100 column. The pooled fractions 30-34 from the gel filtration column were passed through a ConA-Sepharose column and a Jacalin-agarose column to remove some plasma glycoproteins. The flow-through fractions from the lectin affinity columns were concentrated and separated on an anion exchange HPLC column. A single small IEARase peak was present in fractions 26-28, and a [3H]DFP labeling experiment indicated that these fractions contained a single radioactive band at 35 kDa (data not shown). As shown on an SDS-polyacrylamide gel stained with Coomassie Blue, this band was prominent and well separated from other proteins (Fig. 1C). This 35-kDa band and a 25-kDa band were shifted to a 48-kDa position under nonreducing conditions (see Fig. 5), which suggests that the proteinase, named PAP-2, is composed of a catalytic heavy chain (35 kDa) and a regulatory light chain (25 kDa) linked by a disulfide bond. The first 29 residues of the 35-kDa polypeptide were determined to be Ile-Leu-Gly-Gly-Glu-Ala-Thr-Ala-Ile-Asp-Gln-Tyr-Pro-Trp-Leu-Ala-Leu-Ile-Glu-Tyr-His-Lys-Leu-Ala-Glu-Ile-Lys-Leu-Met (Fig. 2). This sequence is similar to a region at the beginning of the catalytic domain in PPAE from the silkworm Bombyx mori (12). The amino terminus of the 25-kDa light chain starts with a pyro-Glu residue, since, after deblocking with pyroglutamate aminopeptidase, the newly exposed sequence was determined to be Ala-(Cys)-Thr-Leu-Pro-Asn (Fig. 2).


View larger version (70K):
[in this window]
[in a new window]
 
Fig. 2.   Nucleotide and deduced amino acid sequence of M. sexta PAP-2. Amino acid residues, shown in one-letter codes, are aligned with the first nucleotide of each codon. The secretion signal peptide is underlined. The double underlined sequence of the mature protein was confirmed by deblocking and sequencing of the PAP-2 light chain (Fig. 1C). The proteolytic activation site is indicated (∥), and the double-underlined sequence after that was determined by Edman degradation sequencing of the 36-kDa PAP-2 heavy chain. Putative N- and O-linked glycosylation sites are marked (+). The catalytic residues at the active site are indicated with asterisks, and residues determining the primary specificity of PAP-2 are labeled (@). A polyadenylation signal (AATAAA, underlined) near the 3'-end of the coding region is probably used for generating a short form of the mRNA, which ends at nucleotide 1365 followed by a 19-nucleotide poly(A) tail.

Molecular Cloning and Structural Features of PAP-2-- We designed two degenerate primers encoding part of the amino-terminal sequence of the 35-kDa polypeptide. Using these primers along with a vector-specific primer (T7) and a degenerate primer based on a conserved sequence around the active site serine, we obtained a 0.6-kb cDNA fragment in a nested polymerase chain reaction and cloned it into a pGem-T plasmid vector. Sequence analysis confirmed that the cDNA encoded a sequence starting with Leu-Ala-Leu-Ile-Glu-Tyr-His-Lys-Leu-Ala-Glu-Ile-Lys-Leu-Met. The rest of the sequence is typical of a serine proteinase from the S1 family (25). Using the 32P-labeled cDNA fragment as a probe, we screened a bacteria-induced M. sexta larval fat body cDNA library. Approximately 1.0 × 103 positives were found in the first round screening of 6.0 × 105 plaques, indicating that PAP-2 mRNA is abundant at 24 h after immune challenge. Plaque purification and in vivo excision of phagemids were carried out with 16 of the putative positive clones. Sequence analysis of their 3' termini indicated that these clones are all identical except for clone 4. Therefore, we determined the complete nucleotide sequences of clone 2 (the longest) and clone 4.

Clone 2 encompasses a 2299-nucleotide cDNA, which includes a complete open reading frame spanning nucleotides 34-1359 (Fig. 2). The same coding region was found in clone 4 with a few nucleotide substitutions, most of which do not alter the amino acid sequence. A significant difference occurs in the 3'-untranslated regions of the two sequences; clone 2 contains 915 nucleotides between the stop codon and poly(A) tail, but clone 4 has only six. Apparently, in clone 4 the AATAAA sequence near the end of the coding region was recognized as a signal for polyadenylation. Northern blot analysis (Fig. 3) indicated that this 1.4-kb form may represent a small but significant portion of the total PAP-2 mRNA population.


View larger version (50K):
[in this window]
[in a new window]
 
Fig. 3.   Changes in PAP-2 mRNA and protein levels in bacteria-challenged M. sexta larvae. A, total RNA samples (10 µg) from hemocytes of control insects (CH), hemocytes collected 24 h after injection of E. coli (IH), fat body of control insects (CF), or fat body collected 24 h after injection of E. coli (IF) were separated by electrophoresis on a 1% agarose gel containing formaldehyde. Northern blot analysis was performed using 32P-labeled M. sexta PAP-2 cDNA as a probe (upper panel). The positions of RNA standards are shown on the right side, and the PAP-2 mRNA is marked with an arrow. Approximately equal loading of each lane was confirmed by hybridizing a duplicate blot with 32P-labeled cDNA for M. sexta ribosomal protein S3 (lower panel) (21). B, cell-free hemolymph samples (1 µl) collected 24 h after fifth instar day 2 larvae had been injected with water, killed E. coli cells, or M. luteus; were treated with SDS sample buffer containing beta -mercaptoethanol; and were separated by SDS-polyacrylamide gel electrophoresis on a 10% gel. Immunoblot analysis was carried out using antiserum against proPAP-2 as the first antibody. The proPAP-2 band is indicated with an arrow. Molecular masses of the protein standards are marked on the right.

The deduced amino acid sequence of PAP-2 is 441 residues long, including a predicted 19-residue secretion signal peptide, which is consistent with the experimentally determined N-terminal sequence of the mature PAP-2: pyro-Glu-Ala-Cys-Thr-Leu-Pro-Asn. The molecular mass of mature proPAP-2 (deduced from clone 2) is 45,780 Da. Potential N-linked and O-linked glycosylation sites are identified in the sequence as Asn219, Asn349, and Ser133. The calculated isoelectric point of proPAP-2 is 6.0. Based on N-terminal sequence of the proteinase catalytic domain, which perfectly matches that deduced from the cDNAs, the activation cleavage site is located between Lys153 and Ile154. The light chain (residues 20-172; 16,429 Da) of PAP-2 contains 25 acidic and 18 basic residues, whereas the heavy chain (residues 173-441, 29,373 Da) has 26 acidic and 36 basic residues. The calculated pI values are 4.7 for the N-terminal regulatory domain and 8.9 for the C-terminal catalytic domain. The catalytic domain is similar in sequence to serine proteinases of the chymotrypsin family, including the conserved catalytic triad consisting of His198, Asp265, and Ser372. Based on the results from a multiple sequence alignment (data not shown), the primary substrate specificity pocket is composed of Asp366, Gly393, and Gly404, suggesting that PAP-2 has a specificity for cleavage after basic residues.

Similar to the silkworm PPAE (12), the mature proPAP-2 contains 24 cysteine residues, which may form 12 disulfide bonds (Fig. 2). The protein contains two clip domains at the amino-terminal end between Ala2 and Pro56 and between Ser62 and Gly114. The connection between the clip domains (Glu-Ser-Asp-Thr-Leu) is longer than that of B. mori PPAE, in which Cys-6 of clip domain-1 and Cys-1 of clip domain-2 are separated by a single Pro residue (12).

Induced Expression of proPAP-2 Gene-- To test whether transcription of the proPAP-2 gene is up-regulated upon immune challenge, we carried out a Northern blot analysis of RNA from hemocytes and fat body from M. sexta larvae injected with water or killed E. coli (Fig. 3A). PAP-2 mRNA was not detected in the water-injected control or induced hemocyte samples. In induced fat body, a major 2.3-kb RNA band was observed along with a minor 1.4-kb band, which probably correspond to PAP-2 mRNAs represented by cDNA clones 2 and 4.

We constructed a recombinant plasmid (proPAP-2/H6pQE60), which encodes the mature proPAP-2 fused with a hexahistidine tag at its amino terminus, purified the fusion protein by Ni2+ affinity chromatography, and prepared a polyclonal antiserum against proPAP-2.2 Immunoblot analysis did not detect any proPAP-2 in larval hemolymph from naive M. sexta (Fig. 3B), but we observed an inducible 55-kDa band in plasma from insects challenged with E. coli or M. luteus, consistent with the result from Northern blot analysis. The mobility of this band is the same as that of the recombinant proPAP-2 from a baculovirus/insect cell expression system.2 Slightly below the 55-kDa band was another inducible protein at around 52 kDa, which cross-reacts with the proPAP-2 antiserum.

Purification of M. sexta PAP-2 from Bar Stage Hemolymph-- With the polyclonal antiserum available, we detected proPAP-2 in the hemolymph of naive M. sexta larvae in the days just before pupation. At day 5 of the wandering stage, ~10% of the zymogen was converted to active enzyme (PAP-2). Preliminary experiments indicated that almost all PAP-2 was present in the 0-35% ammonium sulfate fraction of the plasma sample and that a beta -1,3-glucan recognition protein was one of the major contaminating proteins in several chromatographic steps in the original purification scheme. Based on these results, an efficient method was developed to purify PAP-2 from the bar stage hemolymph.

First, we incubated the 0-50% ammonium sulfate fraction of the plasma with curdlan in the presence of 0.5 M NaCl and 0.001% 1-phenyl-2-thiourea. Phenoloxidase activity was greatly reduced under these conditions, and beta -1,3-glucan recognition protein bound to the insoluble curdlan. After curdlan and cell debris were removed by centrifugation, ammonium sulfate saturation of the supernatant was slowly adjusted to 35%. The protein precipitate was collected by centrifugation and dissolved in and dialyzed against the hydroxylapatite HT buffer. Compared with the starting material, over 90% of total proteins were removed in this simple step (Table I). However, PAP-2 represented only a small portion of the total IEARpNa-hydrolyzing activity in the sample. PAP-2 (fractions 41-46) was hidden under a broad IEARase peak in fractions 38-52 (Fig. 4A). Guided by results from immunoblot analysis, we pooled fractions 41-46, which contained 90% of PAP-2 loaded. The specific activity was increased ~9.4-fold by this step. The proteins in the combined fractions were collected by ammonium sulfate precipitation and then separated by gel filtration chromatography on a Sephacryl S100-HR column (Fig. 4B). Most of the PAP-2 eluted in fractions 37-44, whereas hydrolysis of IEARpNa was also detected in many other fractions. The last IEARase peak (fractions 52-60) may represent a proteinase that interacts with the column matrix, since its apparent molecular mass is only about 10 kDa, a value much smaller than the size of a typical serine proteinase without a regulatory domain (25 kDa).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Purification of M. sexta PAP-2 from hemolymph of bar stage insects


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 4.   Purification of M. sexta PAP-2 from hemolymph of bar-stage insects. As described under "Experimental Procedures," 0-50% AS-fraction of hemolymph (40 ml) was incubated with curdlan in HT buffer containing phenyl-2-thiourea and p-aminobenzamidine. After refractionation with 0-35% saturated AS and dialysis against the HT buffer, the treated sample was separated on a hydroxylapatite column (A). Fractions containing PAP-2, indicated by the horizontal bar, were pooled and precipitated with 60% saturated AS. The dissolved sample (3.0 ml) was applied to a Sephacryl S100-HR column (B) and eluted as described under "Experimental Procedures." Based on results of immunoblot analysis and amidase activity measurement, fractions containing PAP-2, indicated by a horizontal bar, were combined and subjected to lectin affinity chromatography on a ConA-Sepharose column (5.0 ml). ------, absorbance at 280 nm; diamond ------diamond , amidase activity (units) in 5 µl of the fraction measured with IEARpNa. C, UNO-Q6 anion-exchange chromatography. After dialysis, the ConA flow-through fraction containing PAP-2 was loaded onto an HPLC UNO-Q6 column equilibrated in Q buffer. A linear gradient of 0-0.2 M NaCl was applied for 30 min at a flow rate of 1.0 ml/min. The elution profile was monitored by measurement of absorbance at 280 nm, and 0.5-ml fractions were collected. The PAP-2 peak is denoted by a horizontal bar.

After small amounts of contaminating proteins were removed from the combined fractions by lectin chromatography on ConA-Sepharose, the PAP-2 sample was dialyzed and separated by ion exchange chromatography on an HPLC Q column (Fig. 4C). A major protein peak eluted from the column at about 150 mM NaCl. Most impurities from the loaded protein sample were removed in this step, and the specific activity of PAP-2 increased about 90-fold (Table I). Although PAP-2 is present at a low concentration in bar stage hemolymph of M. sexta, we successfully purified the enzyme with an overall yield of 73% and an increase in specific activity of 6 × 104.

Properties of Purified M. sexta PAP-2-- As indicated by SDS-PAGE (Fig. 5A), purified PAP-2 is near homogeneity with an apparent molecular mass of 48 kDa under nonreducing conditions. In the presence of 0.1 M dithiothreitol, the heavy and light chains of PAP-2 were separated as 35- and 25-kDa bands. Due to possible allelic variations and/or glycosylation differences, microheterogeneity was observed in both polypeptides. Immunoblot analysis (Fig. 5B) indicated that both polypeptide chains were recognized by the polyclonal antibodies, although the polyclonal antiserum appears to recognize the light chain better than the heavy chain. Affinity labeling of the active site serine residue showed that the catalytic domain of M. sexta PAP-2 is located in the 35-kDa chain, which is attached to the unlabeled light chain by a disulfide bond (Fig. 5C). The apparent molecular masses of both chains are greater than the masses calculated from sequence, suggesting that both of the polypeptides are glycosylated (Fig. 2).


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 5.   SDS-polyacrylamide gel electrophoretic analysis of purified M. sexta PAP-2. Purified PAP-2 (50 ng/lane) was treated with SDS sample buffer in the absence or presence of 0.1 M dithiothreitol and separated by electrophoresis on a 12% polyacrylamide gel (18). A, silver staining. B, immunoblot analysis was performed as described in the legend to Fig. 3. C, to affinity-label the active site serine residue of PAP-2, 18 µl of purified PAP-2 (12 µg/µl) was incubated with [3H]DFP (2 µl, 0.1 mM, 10 mCi/mmol) at 37 °C for 1 h. After treatment with SDS sample buffer, the labeling mixture was resolved by electrophoresis on a 12% gel and subjected to fluorography according to Skinner and Griswold (24). Positions of the 14C-labeled molecular mass standards are marked on the right.

We determined by MALDI mass spectrometry that the molecular mass of PAP-2 is 46,450 ± 30 Da (Fig. 6), which is larger than the calculated molecular mass for PAP-2 (45,801 Da). The mass difference (~651 Da) may result from glycosylation at Ser or Asn residues (Fig. 2). In agreement with the results of SDS-PAGE analysis (Fig. 5), we have also detected a shoulder peak at both MH+ and MH2+ positions, which may correspond to a minor component in the PAP-2 preparation. Genetic variations and/or posttranslational modifications could be responsible for the 176-Da mass increase.


View larger version (6K):
[in this window]
[in a new window]
 
Fig. 6.   MALDI time-of-flight mass spectrometry of M. sexta PAP-2. A representative strong single accumulation spectrum for PAP-2 is presented. The spectrum was calibrated with an external bovine serum albumin standard and subjected to noise removal. The mass values are indicated above the MH+ and MH2+ peaks, which are slightly different from the average reported under "Results" (the mean ± S.D., n = 4). Experimental details for sample preparation and mass spectrometry are described under "Experimental Procedures."

Activation of proPO by M. sexta PAP-2 and SPHs-- To test whether purified PAP-2 can activate Manduca proPO, we incubated PAP-2 with proPO for 60 min and detected a low level of PO activity (Fig. 7A). Since the control reaction of proPO alone does not have any PO activity, Manduca PAP-2 must have converted a small amount of proPO to PO. However, the activation reaction was much more efficient in the presence of a cofactor.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 7.   Effect of M. sexta SPH-1 and SPH-2 on the activation of prophenoloxidase by PAP-2. A, PO activity. Buffer, SPHs (5 ng), PAP-2 (50 ng), or a mixture of PAP-2 and SPHs (50 ng + 5 ng) was incubated with 0.1 µg of purified proPO in 20 mM Tris-HCl, 5 mM CaCl2, pH 7.5, at 4 °C for 60 min. Activated phenoloxidase was assayed using dopamine as a substrate. B, SDS-polyacrylamide gel electrophoretic analysis. Purified proPO (0.125 µg) was reacted with buffer (lanes 1 and 4), 20 ng of PAP-2 (lanes 2 and 5), or a mixture of 20 ng of PAP-2 and 7.5 ng of SPHs (lanes 3 and 6) in the absence (lanes 1-3) or presence (lanes 4-6) of 0.001% PTU. The reaction mixtures were treated with SDS-sample buffer containing beta -mercaptoethanol, separated by electrophoresis on a 6% polyacrylamide gel, and visualized by silver staining. C, immunoblot analysis. Purified proPO (0.1 µg) was incubated with buffer (lane 1) or a mixture of 50 ng of PAP-2 and 30 ng of SPHs in the absence (lane 2) or presence (lane 3) of PTU. The activation mixtures were subjected to SDS-polyacrylamide gel electrophoresis under reducing conditions. Immunoblot analysis was performed using 1:2000 diluted antiserum against proPO as the first antibody. Positions of the prestained molecular weight standards are indicated on the right.

We have isolated from M. sexta hemolymph two SPHs that bind to a C-type lectin, M. sexta immulectin-2 (13, 14). cDNA cloning indicates that both SPHs lack a Ser residue at the expected position of the active site. Neither protein, therefore, is expected to have a catalytic activity. However, they are similar in amino acid sequence to prophenoloxidase-activating factor (PPAF)-III from a coleopteran insect, Holotrichia diomphalia (27). PPAF-III is a serine proteinase-like protein that assists PPAF-I in the conversion of proPO to PO. The M. sexta SPHs and H. diomphalia PPAF-III contain a clip domain at their amino termini. Because of the sequence similarity, we tested whether the M. sexta SPHs can serve as cofactors of PAP-2. In the control reactions, proPO and SPHs did not have PO activity (Fig. 7A). After proPO was incubated with PAP-2 and SPHs, however, we detected phenoloxidase activity at a level much higher than the control reactions of proPO with either PAP-2 or SPHs. These results indicate that the SPHs are required for efficient activation of proPO by PAP-2.

To explore the mechanism of proPO activation, we separated the reaction mixtures by electrophoresis on an SDS-polyacrylamide gel followed by either silver staining (Fig. 7B) or immunoblot analysis (Fig. 7C). M. sexta proPO is composed of 79-kDa proPO-p1 and 80-kDa proPO-p2 (17). After proPO had been incubated with PAP-2 for 1 h, a 74-kDa protein was generated, which was recognized by antibodies against proPO-p2 (data not shown). Therefore, we concluded that a significant amount of proPO-p2 was converted to a 74-kDa product, although a low level of PO activity was detected (Fig. 7A). In contrast, the cleavage of proPO-p1 was hardly detected. When proPO was reacted with PAP-2 in the presence of the SPHs, the 74-kDa band became more prominent. In addition, several other bands were detected: one at about 140 kDa and two at greater than 250 kDa (Fig. 7B), which were recognized by antibodies against Manduca proPO (Fig. 7C). These may be protein complexes that contain PO or PO oligomers. The protein complexes appear to be connected through covalent bonds, since they are present after the reaction mixture was separated by SDS-polyacrylamide gel electrophoresis under reducing conditions. To test whether active phenoloxidase itself is required for the oligomer formation, we included a PO inhibitor (PTU) in the activation mixture. While the conversion of proPO-p2 to its 74-kDa form was not affected, we did not detect any high molecular weight complex in the presence of PO inhibitor (Fig. 7, B and C). Thus, active PO may be involved in formation of covalent cross-links between proteins to form the observed high molecular weight species.

Determination of Cleavage Site in proPO-- To further characterize the proPO activation reaction, we used MALDI mass spectrometry to determine the site at which PAP-2 cleaves proPO (Fig. 8). In the control samples of PAP-2 or proPO only, we did not detect any significant mass peak within the range from 2500 to 6500 Da (data not shown). However, after Manduca proPO was incubated with PAP-2, we detected a major peak at 5851 Da and a corresponding MH2+ peak of 2926 Da. There was also a small peak of 6032 Da in the spectrum. These peaks probably correspond to the propeptides released from proPO-p1 and proPO-p2 as a result of proteolytic cleavage by PAP-2. Previous study indicated that proPO-p1 and proPO-p2 are blocked at the amino terminus (17). We calculated the molecular masses for the putative 50-residue propeptides to be 5990 Da for proPO-p1 and 5808 Da for proPO-p2. Taking into account the accuracy of MALDI time-of-flight mass spectrometry, the mass differences between the theoretical and observed mass values (42 Da for propeptide 1 and 43 Da for propeptide 2) are in good agreement with N-acetylation of the amino-terminal residue. The silkworm proPO-p1 and proPO-p2, cleaved by PPAE at Arg51, were also found to be N-acetylated (28).


View larger version (8K):
[in this window]
[in a new window]
 
Fig. 8.   MALDI time-of-flight mass spectrometry of propeptides released from proPO after PAP-2 cleavage. The reaction mixture of proPO and PAP-2 was desalted and eluted from a C18 zip tip. A representative strong single accumulation spectrum is presented. The spectrum was subjected to noise removal and calibrated with external standards of bovine insulin, E. coli thioredoxin, and horse apomyoglobulin. The mass values are indicated above the MH+ and MH2+ peaks. Other experimental details are described under "Experimental Procedures."


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

As an integral part of the host defense system against invading pathogens and parasites, prophenoloxidase activation has been investigated in various insects and crustaceans for more than 30 years (3, 4). Even so, our knowledge of the prophenoloxidase-activating cascade is rather limited. A major breakthrough currently occurring in this field is the isolation and molecular cloning of clip domain serine proteinases that directly activate prophenoloxidase through limited proteolysis (9, 12, 30, 31). We previously isolated PAP-1 from M. sexta and cloned a cDNA encoding the proPAP-1 zymogen (9). PAP-1 contains a single amino-terminal clip domain. proPO-activating proteinases from the beetle H. diomphalia (30) and from a crayfish Pacifastacus leniusculus (31) also contain one clip domain. In this paper, we describe a second PAP from M. sexta, PAP-2. PAP-2 is most similar to the silkworm PPAE (12). M. sexta PAP-2 and silkworm PPAE contain two amino-terminal clip domains with 24 cysteine residues that are perfectly aligned. The functions of clip domains in arthropod serine proteinases are not yet well established. It seems likely that they are involved in regulating the enzymes' activity or localization. The clip domain in the crayfish proteinase exhibits antibacterial activity toward Gram-positive bacteria (31). If clip domains interact with bacteria to exert an antimicrobial function, they might also anchor the PAP-2 catalytic domain that converts proPO to PO onto a bacterial surface. Clip domains linked to serine proteinases may have multiple functions in arthropod immune responses (10).

The two PAPs we have identified in M. sexta have some similarities and some differences in their patterns of expression. M. sexta PAP-1 was initially isolated from a prepupal cuticular extract, and its mRNA is present in prepupal epidermis.3 PAP-1 mRNA was also detected in fat body of naive (no microbial injection) feeding stage larvae, and proPAP-1 is present in hemolymph of naive larvae (32). Upon bacterial challenge, the concentration of proPAP-1 protein increases in hemolymph, as transcription of the PAP-1 gene is up-regulated in fat body and hemocytes during immune responses (9, 32). However, neither proPAP-2 nor its mRNA was detected in naive feeding stage larvae (Fig. 3). During the larval stage, PAP-2 expression was only observed after microbial challenge. However, we did detect proPAP-2 and active PAP-2 in hemolymph of naive prepupal insects, but PAP-1 was not present in hemolymph at this stage.4 These results suggest that the transcription of the PAP genes might be regulated by developmental and immune pathways. Hormonal signals (presumably ecdysteroids) prior to pupation may stimulate expression of PAP-1 in epidermis and PAP-2 in fat body, whereas both genes are expressed in fat body in response to microbial infection. The existence of more than one PAP in M. sexta indicates that the proPO-activating cascade in this species is more complex than previously expected.

Purified M. sexta PAP-1 and PAP-2 require the presence of a nonproteolytic protein cofactor for proPO-activating function, although they can hydrolyze a small peptide substrate in the absence of the cofactor (Fig. 1) (9). The cofactors responsible for this modulation of PAP activity appear to be SPHs, which have a structure similar to the PAPs themselves. These SPHs contain an amino-terminal clip domain and a carboxyl-terminal proteinase-like domain, but their active site serine residue is replaced with glycine (13). The SPHs isolated from M. sexta plasma are a mixture of two related proteins, which we have not yet been able to separate. We are pursuing experiments with recombinant SPHs to determine whether one or both of the SPHs interact with PAP-1 and PAP-2.

Similar to M. sexta PAP-1 and PAP-2, PPAF-I from a beetle, H. diomphalia, was also reported to require a proteinaceous factor, PPAF-II or PPAF-III, to activate proPO (27, 30). cDNA cloning revealed that PPAF-III is a serine proteinase homolog containing a clip domain. H. diomphalia PPAF-I cuts proPO at Arg51 to generate an inactive intermediate. When a 40-kDa PPAF-II was also present, proPO was cleaved at an additional site (Arg at around position 165) to yield active PO. Under our experimental conditions, PAP-2 cleaved proPO at Arg51 in the absence of SPH, and we did not observe a secondary cleavage site in proPO after incubation with PAP-2 and SPHs (Fig. 7). In contrast to the proteinases from M. sexta and H. diomphalia, the silkworm PPAE, which contains two clip domains like PAP-2, does not appear to require any protein cofactor for the activation (12). The reason for this difference is not clear. Perhaps in vivo at a low enzyme concentration, the silkworm PPAE may also interact with SPH or other protein cofactors.

Nonself recognition, an essential first step of the insect immune responses against microorganisms, is mediated by hemolymph proteins that specifically bind to molecules present on the surface of invading pathogens, such as lipopolysaccharide and peptidoglycan from bacteria or glucans and mannans from fungi (33, 34). Lectins involved in proPO activation (14, 35) and some cellular defense responses (36) have been identified in several insect species. M. sexta immulectin-2, a C-type lectin, binds to bacterial lipopolysaccharide, interacts with the SPHs, and stimulates proPO activation in response to lipopolysaccharide (14, 15).

It can be envisioned that bacterial infection results in formation of a protein complex, containing immulectin-2 bound to the bacterial surface and interacting with SPHs, which bring PAP and proPO together in a suitable orientation for activation of proPO by PAP-1 or PAP-2 (13). Such a complex serves the purpose of activating proPO and localizing the active enzyme at a microbial surface. We observed that activation of proPO by PAP-2 in the presence of SPHs resulted in the formation of high molecular weight species that contained PO (Fig. 7) but not PAP-2 or SPH.4 Therefore, we interpret these bands, detected in SDS-PAGE and immunoblot analysis, to represent covalently linked oligomers of PO or PO associated with other proteins, because they were not dissociated by 1% SDS. Formation of the oligomers did not occur in the presence of a PO inhibitor, indicating that the PO enzymatic activity is required to cross-link the proteins, perhaps through oxidation of tyrosine residues. Beck et al. (26) observed a high molecular weight protein complex, including proPO and PO, that formed in M. sexta plasma only when the hemolymph was collected under nonsterile conditions, suggesting that it was a response to the presence of microorganisms. Formation of a protein complex at a surface is a common feature of serine proteinase cascade pathways such as the vertebrate blood coagulation and complement systems. A similar process may occur in arthropod proPO activation cascades, serving to activate proteinases in discrete locations near the surface of pathogens. We are planning to express the PAPs, SPHs, and their individual clip and proteinase domains as recombinant proteins for further studies to understand the interactions among the protein factors involved in proPO activation in M. sexta.

    ACKNOWLEDGEMENTS

We thank Gary Radke at the KSU Microchemical Laboratory for amino acid sequence analysis and Dr. Steve Hartson at OSU Recombinant DNA/Protein Resource Facility for MALDI mass determination. We also thank Drs. Dilwith, Sauer, Gorman, and Kramer for helpful comments on the manuscript.

    FOOTNOTES

* This work was supported in part by National Institutes of Health Grants GM58634 (to H. J.) and GM41247 (to M. K.). This article was approved for publication by the Director of the Oklahoma Agricultural Experimental Station and supported in part under project OKLO2450. This is contribution 02-448-J from the Kansas Agricultural Experiment Station.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AY077643.

§ To whom correspondence should be addressed: Dept. of Entomology and Plant Pathology, Oklahoma State University, Stillwater, OK 74078. Tel.: 405-744-9400; Fax: 405-744-6039; E-mail: haobo@okstate.edu.

Published, JBC Papers in Press, November 26, 2002, DOI 10.1074/jbc.M205743200

2 C. Ji, Y. Wang, J. Ross, and H. Jiang, manuscript in preparation.

3 Y. Wang and H. Jiang, unpublished results.

4 Y. Wang and H. Jiang, unpublished data.

    ABBREVIATIONS

The abbreviations used are: PO, phenoloxidase; PAP, prophenoloxidase-activating proteinase; proPAP, precursor of proprophenoloxidase-activating proteinase; PPAE, prophenoloxidase-activating enzyme; PPAF, prophenoloxidase-activating factor; SPH, serine proteinase homolog; proPO, prophenoloxidase; DFP, diisopropyl fluorophosphate; IEARpNa, acetyl-Ile-Glu-Ala-Arg-p-nitroanilide; PTU, 1-phenyl-2-thiourea; MALDI, matrix-assisted laser desorption ionization; ConA, concanavalin A; HPLC, high performance liquid chromatography; IEARase, IEARpNa-hydrolyzing enzyme.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Ashida, M., and Yamazaki, H. (1990) Molting and Metamorphosis , 1st Ed. , pp. 239-265, Japan Scientific Society Press, Tokyo
2. Sugumaran, M. (1996) in New Directions in Invertebrate Immunology (Söderhäll, K. , Iwanaga, S. , and Vasta, G., eds), 1st Ed. , pp. 355-374, SOS Publications, Fair Haven, NJ
3. Ashida, M., and Brey, P. T. (1998) Molecular Mechanisms of Immune Responses in Insects , 1st Ed. , pp. 135-172, Chapman & Hall, London
4. Nappi, A. J., and Vass, E. (2001) Adv. Exp. Med. Biol. 484, 329-348[Medline] [Order article via Infotrieve]
5. Sugumaran, M., and Kanost, M. R. (1993) Parasites and Pathogens of Insects , 1st Ed. , pp. 317-342, Academic Press, Inc., New York
6. Kanost, M. R., Jiang, H., Wang, Y., Yu, X., Ma, C., and Zhu, Y. (2001) Adv. Exp. Med. Biol. 484, 319-328[Medline] [Order article via Infotrieve]
7. Gillespie, J. P., Kanost, M. R., and Trenczek, T. (1997) Annu. Rev. Entomol. 42, 611-643[CrossRef][Medline] [Order article via Infotrieve]
8. Kanost, M. R. (1999) Dev. Comp. Immunol. 23, 291-301[CrossRef][Medline] [Order article via Infotrieve]
9. Jiang, H., Wang, Y., and Kanost, M. R. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 12220-12225[Abstract/Free Full Text]
10. Jiang, H., and Kanost, M. R. (2000) Insect Biochem. Mol. Biol. 30, 95-105[CrossRef][Medline] [Order article via Infotrieve]
11. Gorman, M. J., and Paskewitz, S. M. (2001) Insect Biochem. Mol. Biol. 31, 257-262[CrossRef][Medline] [Order article via Infotrieve]
12. Satoh, D., Horii, A., Ochiai, M., and Ashida, M. (1999) J. Biol. Chem. 274, 7441-7453[Abstract/Free Full Text]
13. Yu, X-Q., Jiang, H., Wang, Y., and Kanost, M. R. (2003) Insect Biochem. Mol. Biol., in press
14. Yu, X-Q., and Kanost, M. R. (2000) J. Biol. Chem. 275, 37373-37381[Abstract/Free Full Text]
15. Yu, X-Q., and Kanost, M. R. (2001) Adv. Exp. Med. Biol. 484, 191-194[Medline] [Order article via Infotrieve]
16. Dunn, P., and Drake, D. (1983) J. Invertebr. Pathol. 41, 77-85
17. Jiang, H., Wang, Y., Ma, C., and Kanost, M. R. (1997) Insect Biochem. Mol. Biol. 27, 835-850[CrossRef][Medline] [Order article via Infotrieve]
18. Laemmli, U. K. (1970) Nature 227, 680-685[Medline] [Order article via Infotrieve]
19. Sambrook, J., and Russell, D. W. (2001) Molecular Cloning: A Laboratory Manual , 3rd Ed. , pp. 2.90-2.100, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
20. Wang, Y., Willott, E., and Kanost, M. R. (1995) Insect Mol. Biol. 4, 113-123[Medline] [Order article via Infotrieve]
21. Jiang, H., Wang, Y., and Kanost, M. R. (1996) Insect Mol. Biol. 5, 31-38[Medline] [Order article via Infotrieve]
22. Ma, C., and Kanost, M. R. (2000) J. Biol. Chem. 275, 7505-7514[Abstract/Free Full Text]
23. Switzer, R. C., Merril, C. R., and Shifrin, S. (1979) Anal. Biochem. 98, 231-237[Medline] [Order article via Infotrieve]
24. Skinner, M. K., and Griswold, M. D. (1983) Biochem. J. 209, 281-284[Medline] [Order article via Infotrieve]
25. Rawlings, R. D., and Barrett, A. J. (1993) Biochem. J. 290, 205-218[Medline] [Order article via Infotrieve]
26. Beck, G., Cardinale, S., Wang, L., Reiner, M., and Sugumaran, M. (1996) J. Biol. Chem. 271, 11035-11038[Abstract/Free Full Text]
27. Kwon, T. H., Kim, M. S., Choi, H. W., Joo, C. H., Cho, M. Y., and Lee, B. L. (2000) Eur. J. Biochem. 267, 6188-6196[Abstract/Free Full Text]
28. Kawabata, T., Yasuhara, Y., Ochiai, M., Matsuura, S., and Ashida, M. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 7774-7778[Abstract]
29. Söderhäll, K. (1996) in New Directions in Invertebrate Immunology (Sönderhäll, K. , Iwanaga, S. , and Vasta, G., eds), 1st Ed. , pp. 229-253, SOS Publications, Fair Haven, NJ
30. Lee, S. Y., Kwon, T. H., Hyun, J. H., Choi, J. S., Kawabata, S., Iwanaga, S., and Lee, B. L. (1998) Eur. J. Biochem. 254, 50-57[Abstract]
31. Wang, R., Lee, S. Y., Cerenius, L., and Söderhäll, K. (2001) Eur. J. Biochem. 268, 895-902[Abstract/Free Full Text]
32. Wang, Y., Jiang, and Kanost, M. R. (2001) Protein Expression Purif. 23, 328-337[CrossRef][Medline] [Order article via Infotrieve]
33. Vasta, G. R., Ahmed, H., and Quesenberry, M. S. (1996) in New Directions in Invertebrate Immunology (Sönderhäll, K. , Iwanaga, S. , and Vasta, G., eds), 1st Ed. , pp. 189-227, SOS Publications, Fair Haven, NJ
34. Nigam, Y., Azambuja, P., and Ratcliffe, N. A. (1996) in New Directions in Invertebrate Immunology (Sönderhäll, K. , Iwanaga, S. , and Vasta, G., eds), 1st Ed. , pp. 399-442, SOS Publications, Fair Haven, NJ
35. Chen, C., Rowley, A. F., Newton, R. P., and Ratcliffe, N. A. (1999) Comp. Biochem. Physiol. B Biochem. Mol. Biol. 122, 309-319[CrossRef][Medline] [Order article via Infotrieve]
36. Caesium, N., Imamura, M., Kadotani, T., Yaoi, K., Iwahana, H., and Sato, R. (1999) FEBS Lett. 443, 139-143[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.